Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose is to compare the intraocular pressure reducing effect of Xalatan with
that of usual care over 36 months. Safety and health care utilization will be evaluated.